A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment
塞库金单抗
医学
强直性脊柱炎
脊柱炎
疾病
内科学
胃肠病学
外科
银屑病性关节炎
作者
Atul Deodhar,Alan Kivitz,Marina Magrey,Jessica A. Walsh,Philip J. Mease,Maria Greenwald,Farid Kianifard,Chelsea Elam,Gopi M Bommidi,Adam Winseck,Lianne S. Gensler
出处
期刊：Rheumatology [Oxford University Press] 日期：2024-08-09
To investigate the clinical response at week 52 in patients with ankylosing spondylitis (AS) who received secukinumab 300 vs 150 mg after inadequate response to 150 mg at week 16.
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
个性的迎波
鸟兽兽
干净的琦
热心市民小红花
GingerF
2052669099
平常丝
贪玩的秋柔
淡淡的酸奶
识字岭的岭
无极微光
Untitled
tuanheqi
CaseyMelkus
chenjzhuc
泽豫
愔愔
MchemG
嘉心糖
皖公网安备34019202002308
